Back to the Top
The following message was posted to: PharmPK
Rick Cothern and I recently published Introduction to Risk Analysis: A
Systematic Approach to Science-Based Decision Making. [ISBN: 0-86587-696-7,
Hardcover, 433 pages (2000) Government Institutes, Rockville, MD, $99.00 (US)
http://www.govinst.com/pubscatalog/products/696.html]
Introduction to Risk Analysis examines risk and the structure of its analysis.
The book is self-contained and suitable for either self-study or classroom use.
Emphasizing prediction, we cover the qualitative nature of risk and explore
quantitative topics, including graphing data, logarithmic thinking, and risk
estimation. The text focuses on fundamental aspects of risk, using
environmental and health risks as its primary examples. The book separately
takes up pharmacokinetics and the use of animal data in deriving potency
estimates. It emphasizes human health risk as its primary example of risk
assessment and covers exposure assessment, dosimetry, epidemiology, toxicology,
and risk characterization in separate chapters within an integrated framework.
Other chapters include a discussion of functions, models, and
uncertainties; the
regulatory process; comparative risk assessment; ecological risk assessment;
risk management; and risk communication. The book also includes several case
studies, references to additional literature, addresses to related Internet
sites, and more than 50 figures.
The treatment of dosimetry will seem simplistic for readers of this listserver,
but Introduction to Risk Analysis shows pharmacokineticists how their data and
interpretations fit into a broader perspective about the risks of regulated
substances and processes. The book features the policies of
regulatory agencies
concerned with health, safety, and environmental risks, including CPSC, OSHA,
EPA, USDA, DOT, FDA, NRC, and state agencies. It will enable professionals to
understand and initiate regulatory risk analyses independently. Additional
information about the book is available at www.ctraps.com.
---
Daniel M. Byrd III, Ph.D., D.A.B.T.
Consultants in Toxicology, Risk Assessment and Product Safety
Suite N707
560 N Street, SW
Washington, DC 20024
(202)484-7707 - phone
(202)484-0616 - fax
ctraps.aaa.radix.net - email
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)